HBLYX | JIAIX | HBLYX / JIAIX | |
Total Expense Ratio | 0.67 | 0.69 | 97% |
Annual Report Gross Expense Ratio | 0.67 | 0.81 | 83% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 9.048 | 9.662 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 250000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 112M | 10,536% |
Annual Yield % from dividends | 3.44 | 5.58 | 62% |
Returns for 1 year | 2.51 | 8.66 | 29% |
Returns for 3 years | 25.18 | 38.42 | 66% |
Returns for 5 years | 17.35 | 24.09 | 72% |
Returns for 10 years | 48.84 | 51.46 | 95% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 42.07 | 0.06 | +0.14% |
Eventide Healthcare & Life Sciences N | |||
IJPTX | 12.35 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
FZALX | 29.92 | N/A | N/A |
Fidelity Advisor Mega Cap Stock Z | |||
MSCUX | 11.42 | N/A | N/A |
Morgan Stanley American Resilience A | |||
AIOIX | 11.50 | -0.06 | -0.52% |
American Century International Opps Inv |